Genomic abnormalities in ALKBH7 significantly reduced CD8+ T-cell immune infiltration, while CD8+ T-cell depletion significantly reduced immune surveillance capacity and the ability to clear tumor cells [39–41]. The gene discussed is ALKBH7; the disease is neoplasm.